Small-molecule inhibitor AZIN32 and application of small-molecule inhibitor AZIN32 in pharmacy
A small molecule inhibitor, AZIN32 technology, applied in the field of biomedicine, can solve problems such as poor curative effect and patient side effects, and achieve the effects of reducing content, inhibiting growth, and interfering with cellular polyamine metabolism
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Pharmacophore Screening Results
[0021] Taking the crystal structure of AZIN (3BTN.pdb) as the initial structure, the pocket detection module was used to find possible binding sites in the receptor, and a total of 5 possible binding sites were found. Combining the mutation data of the binding interface of AZ and AZIN, the pocket containing the most binding interface residues was selected for further screening of small molecule inhibitors. Based on the determined key amino acid residue characteristics of the active site, the pharmacophore model of the binding pocket was constructed using the pharmacophore method ( figure 1 ). The constructed pharmacophore model was used to search and screen the SPECS compound database, and the final screened compound was named the small molecule inhibitor AZIN32, which is available for purchase, and its specific structural formula is:
[0022]
Embodiment 2
[0024] Effects of Small Molecule Inhibitor AZIN32 on ODC, AZ, AZIN and Polyamine Contents in PC3 Cells
[0025] 1. Detection of ODC, AZ-1 and AZIN-1 protein content changes in PC3 cells by immunoblotting
[0026] The cells treated with the drug AZIN32 and the control group were collected and lysed with RIPA cell lysate for half an hour, then centrifuged at 12000rmp in a centrifuge to collect the protein, and then the protein was quantified by the BCA method. After electrophoresis separation, the same amount of protein in each group was electrophoretically transferred to PVDF membrane and blocked with 5% skimmed milk (20mmol / L Tris-HCl, 150mmol / L NaCl, 0.05% Tween-20, pH7.4) for one hour Afterwards, overnight incubation with anti-ODC, AZIN-1 and AZ-1 monoclonal antibodies, followed by incubation with polyclonal antibodies for one hour at room temperature. The protein expression was detected by ECL. The result is as figure 2 As shown, compared with the control cells, the ODC...
Embodiment 3
[0030] Antitumor Activity of Small Molecule Inhibitor AZIN32
[0031] AZIN32 effectively inhibits the growth and reproduction of human prostate cancer PC3 cells
[0032] Take PC3 cells in the logarithmic growth phase in 4×10 3 Inoculate a 96-well cell culture plate at a concentration of one per well, and after culturing for 24 hours, add 1640 medium containing the small molecule drug AZIN32 into the cell wells, so that the final concentrations of AZIN32 are 0 μM, 12.5 μM, 25 μM, 50 μM, 75 μM and 100μM (4 replicate wells for each group). At the same time, there were no drug control group and blank group. After continuing to culture for 24h, 48h and 72h respectively, remove the cell culture medium in the culture plate, add MTT reagent with a final concentration of 0.2g / L, incubate at 37°C for 4h, add DMSO 150μL, shake and mix well, and measure the absorbance at 570nm . Cell proliferation inhibition rate=(A control well-A experimental well) / A control well×100%.
[0033] MTT ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com